JCB logo
R&D Systems: New Poster Available
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 2 August 2004. doi:10.1083/jcb1663iti3
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 166, Number 3, 305-305
This Article
Right arrow Full Text (PDF, 686K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wells, W. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wells, W. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

In This Issue

Integrins make a choice



IGF and integrins can collaborate in either adhesion or proliferation.

Signaling researchers have only a few factors with which to explain a whole lot of biology. On page 407, Goel et al. describe how two integrin variants channel the actions of a single factor, insulin-like growth factor (IGF), into two distinct pathways that induce either adhesion or proliferation.

The ß1A integrin variant was known to be associated with proliferation and the ß1C variant to inhibit it. IGF and its receptors had also been found to enhance adhesion through ß1 integrins.

Goel et al. find that, in cells with ß1A integrin, IGF binding to its receptor induces formation of a ternary complex of integrin, IGF receptor and the downstream signaling protein IRS-1. The resultant boost in cell proliferation is, however, prevented by expression of the ß1C integrin. A short insertion in the cytoplasmic tail of ß1C brings in the Gab1 and Shp2 proteins, with the Shp2 phosphatase removing the phosphates that would otherwise have led to IRS-1 recruitment and signaling.

The result is synergistic activation of adhesion by the IGF receptor and ß1C integrin. It is not yet clear which molecular output the IGF receptor is bringing to the adhesion equation. But removal of ß1C with a ribozyme prevents IGF-stimulated adhesion, and ß1C addition to prostate tumor cells before their injection into host animals significantly reduces the size of the resultant tumors. {blacksquare}



William A. Wells

wellsw{at}rockefeller.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF, 686K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wells, W. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wells, W. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents